Induction chemotherapy does not increase the operative risk of pneumonectomy!

European Journal of Cardio-thoracic Surgery

Volumn 31, Issue 2, 2007, Pages 181-185

  Mansour, Ziad ^a   Kochetkova, Evgenia A ^a   Ducrocq, Xavier ^a   Vasilescu, Mircea Dan ^a   Maxant, Guillaume ^a   Buggenhout, Alexis ^a   Wihlm, Jean Marie ^a   Massard, Gilbert ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Chemotherapy; Complications; Pneumonectomy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; NAVELBINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; BRONCHUS FISTULA; COMORBIDITY; DEMOGRAPHY; FEMALE; HUMAN; INCIDENCE; LUNG EMPHYSEMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL RISK; TOBACCO; WEANING;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; EMPYEMA, PLEURAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PNEUMONECTOMY; REMISSION INDUCTION; RESPIRATORY TRACT FISTULA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846424566     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.11.008     Document Type: Article

References (24)

1. Martin J., Ginsberg R., Abolhoda A., Bains M.S., Downey R.J., Korst R.J., Weigel T.L., Kris M.G., Venkatraman E.S., and Rusch V.W. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonctomy. Ann Thorac Surg 72 (2001) 1149-1154
2. Fowler W.C., Langer C.J., Curran W.J., and Keller S.M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thor Surg 55 (1993) 986-989
3. Roberts J.R., Eustis C., Devore R., Carbone D., Choy H., and Johnson D. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thor Surg 72 (2001) 885-888
4. Doddoli C., Thomas P., Thirion X., Serée Y., Giudicelli R., and Fuentes P. Postoperative complications in relation with induction therapy for lung cancer. Eur J Cardiothorac Surg 20 (2001) 385-390
5. Matsubara Y., Takeda S., and Mashimo T. Risk stratification for lung cancer surgery. Chest 128 (2005) 3519-3525
6. Doddoli C., Barlesi F., Trousse D., Robitail S., Yena S., Astoul P., Giudicelli R., Fuentes P., and Thomas P. One hundred consecutive pneumonectomies after induction therapy for non-small lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 130 (2005) 416-425
7. Siegenthaler M.P., Pisters K.M., Merriman K.W., Merriman K.W., Roth J.A., Swisher S.G., Walsh G.L., Vaporciyan A.A., Smythe W.R., and Putnam J.B. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 71 (2001) 1105-1112
8. Stamatis G., Djuric D., Eberhardt W., Pöttken C., Zaboura G., Fechner S., and Fujimoto T. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg 22 (2002) 292-297
9. Van Schil P., Van Meerbeeck J., Kramer G., Splinter T., Legrand C., Giaccone G., Manegold C., and Van Zandwijk N. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur Respir J 26 (2005) 192-197
10. Perrot E., Guibert B., Mulsant P., Blandin S., Arnaud I., Roy P., Geriniere L., and Souquet P.J. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection. Ann Thorac Surg 80 (2005) 423-427
11. Port J.L., Korst R.J., Lee P.C., Levin M.A., Becker D.E., Keresztes R., and Altorki N.K. Sugical resection for residual N2 disease after induction chemotherapy. Ann Thorac Surg 79 (2005) 1686-1690
12. Nagai K., Tsuchiya R., Mori T., Tada H., Ichinose Y., Koike T., and Kato H. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). J Thorac Cardiovasc Surg 125 (2003) 254-260
13. Barlési F., Doddoli C., Torre J.P., Giudicelli R., Fuentes P., Thomas P., and Astoul P. Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy. Eur J Cardiothorac Surg 28 (2005) 629-634
14. Darling G.E., Abdurahman A., Yi Q.L., Johnston M., Waddell T.K., Pierre A., Keshavjee S., and Ginsberg R. Risk of a right pneumonectomy: role of bronchopleural fistula. Ann Thorac Surg 79 (2005) 433-437
15. Bernard A., Deschamps C., Allen M., Miller D.L., Trastek V.F., Jenkins G.D., and Pairolero P.C. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg 121 (2001) 1076-1082
16. Licker M., Spiliopoulos A., Frey J.G., Robert J., Höhn L., De Perrot M., and Tschopp J.M. Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest 121 (2002) 1890-1897
17. Vaprociyan A.A., Merriman K.W., Ece F., Roth J.A., Smythe W.R., Swisher S.G., Walsh G.L., Nesbitt J.C., and Putnam J.B. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg 73 (2002) 420-426
18. Bueno R., Richards W.G., Swanson S.J., Jaklitsch M.T., Lukanich J.M., Mentzer S.J., and Sugarbaker D.J. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70 (2000) 1826-1831
19. Mateu-Navarro M., Rami-Porta R., Bastus-Piulats R., Cierra-Nogueras L., and González-Pont G. Remediastinoscopy after induction therapy in non-small cell lung cancer. Ann Thorac Surg 70 (2000) 391-395
20. Van Schil P., Van der Schoot J., Poniewierski J., Pauwels M., Carp L., Germonpré P., and De Backer W. Remediastinoscopy after neoadjuvant therapy in non-small cell lung cancer. Lung Cancer 37 (2002) 281-285
21. Pass H.I., Pogrebniak H.W., Steinberg S.M., Mulshine J., and Minna J. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 53 (1992) 992-998
22. Rosell R., Gomez-Codina J., Camps C., Maestre J., Padilla J., Canto A., Mate J.L., Li S., Roig J., Olazabal A., Canela M., Ariza A., Skacel Z., Morera-Prat J., and Abad A. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell cancer. N Engl J Med 330 (1994) 153-158
23. Roth J.A., Atkinson E.N., Fossella F., Komaki R., Bernadette Ryan M., Putnam J.B., Lee J.S., Dhingra H., De Caro L., Chasen M., and Hong W.K. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21 (1998) 1-6
24. Depierre A., Milleron B., Moro-Sibilot D., Chevret S., Quoix E., Lebeau B., Braun D., Breton J.L., Lemarié E., Gouva S., Paillot N., Bréchot J.M., Janicot H., Lebas F.X., Terrioux P., Clavier J., Foucher P., Monchâtre M., Coëtmeur D., Level M.C., Leclerc P., Blanchon F., Rodier J.M., Thiberville L., Villeneuve A., Westeel V., and Chastang C. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIa non-small cell lung cancer. J Clin Oncol 20 (2002) 247-253